E. Benedetti
YOU?
Author Swipe
View article: Outcome After Intestinal Transplantation From Living Versus Deceased Donors
Outcome After Intestinal Transplantation From Living Versus Deceased Donors Open
View article: Status 1A ABO Incompatible Liver Transplant With Eculizumab as a Rescue Treatment for a Patient With Primary Non-Function: Case Report
Status 1A ABO Incompatible Liver Transplant With Eculizumab as a Rescue Treatment for a Patient With Primary Non-Function: Case Report Open
Primary graft non-function (PNF) after liver transplant (LT) due to graft necrosis necessitates urgent graftectomy and Status 1A liver re-transplant. To find a suitable donor promptly, ABO blood type incompatibility (ABOi) is a crucial imm…
View article: The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety Open
View article: Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial Open
View article: Resistance-Based Muscle Therapy, Frailty, and Muscle Biopsy Findings in Kidney Transplant Candidates: A Clinical Trial
Resistance-Based Muscle Therapy, Frailty, and Muscle Biopsy Findings in Kidney Transplant Candidates: A Clinical Trial Open
One year of muscle rehabilitation therapy resulted in significant improvements in physical performance metrics accompanied by significant improvements in muscle morphology.
View article: A retrospective cohort analysis comparing the effectiveness and safety of perioperative angiotensin II to adrenergic vasopressors as a first-line vasopressor in kidney transplant recipients
A retrospective cohort analysis comparing the effectiveness and safety of perioperative angiotensin II to adrenergic vasopressors as a first-line vasopressor in kidney transplant recipients Open
Background Perioperative adrenergic vasopressors in kidney transplantation have been linked to negative outcomes and arrhythmias. Synthetic angiotensin II (AT2S) could improve renal hemodynamics, preserve allograft function, and reduce arr…
View article: Analyzing the Impact of CIT on the Largest Reported Cohort of Robotic Kidney Transplantation From the Deceased Donors
Analyzing the Impact of CIT on the Largest Reported Cohort of Robotic Kidney Transplantation From the Deceased Donors Open
Background. Robotic-assisted kidney transplant (RAKT) has proven to be a successful approach for patients with morbid obesity and more centers are encouraged to apply robotic approach also for deceased donor kidney transplantation. Prolong…
View article: Timing Considerations for Sleeve Gastrectomy in Kidney Transplant Patients: A Single Center Evaluation
Timing Considerations for Sleeve Gastrectomy in Kidney Transplant Patients: A Single Center Evaluation Open
Current scientific literature is deficient in detailing the optimal timing for conducting bariatric surgery in relation to kidney transplantation. In this study, we performed a retrospective evaluation of kidney transplant recipients with …
View article: Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients Open
Introduction Carmustine (BCNU), etoposide, cytarabine, and melphalan (BEAM) are a widely used high-dose chemotherapy regimen for autologous stem cell transplantation transplant (ASCT) in lymphoid malignancies. During BCNU shortages, some c…
View article: Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Open
Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), is a rare but potentially fatal complication following allogenic hematopoietic cell transplantation (allo-HCT). Timely identification of SOS/VOD to allow fo…
View article: The Role of Colon in Isolated Intestinal Transplantation: Description of 4 Cases
The Role of Colon in Isolated Intestinal Transplantation: Description of 4 Cases Open
Intra‐abdominal desmoid tumors are a rare and complex clinical problem. These tumors are locally invasive, and surgical ablation represents the mainstay of treatment. When localized at the root of the mesentery, their resection may require…
View article: Diagnostic Accuracy of Liver Stiffness Measurement for the Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation (ELASTOVOD STUDY): An Italian Pragmatic Investigator-Initiated, Prospective, Multicentre Diagnostic Clinical Trial
Diagnostic Accuracy of Liver Stiffness Measurement for the Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation (ELASTOVOD STUDY): An Italian Pragmatic Investigator-Initiated, Prospective, Multicentre Diagnostic Clinical Trial Open
View article: Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry
Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry Open
Purpose: The purpose of this study was to evaluate the stability of angiotensin II in 0.9% sodium chloride for up to 5 days. Methods: We prepared angiotensin II dilutions, by aseptically diluting 2.5 mg (1 mL) in 249 mL 0.9% sodium chlorid…
View article: Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients
Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients Open
Introduction Neutropenic enterocolitis (NEC) is a life-threatening complication reported in patients with acute myeloid leukemia (AML) following chemotherapy (CHT). Intensive induction and consolidation CHT may damage intestinal mucosa lea…
View article: POSTER: CLL-130 Update From the Dedalo Protocol: An Integrated Approach to MRD in CLL Patients Receiving Venetoclax Plus Rituximab
POSTER: CLL-130 Update From the Dedalo Protocol: An Integrated Approach to MRD in CLL Patients Receiving Venetoclax Plus Rituximab Open
View article: ARC-ETCRYO and CAOS, two experimental facilities dedicated to Einstein Telescope cryogenics and suspensions
ARC-ETCRYO and CAOS, two experimental facilities dedicated to Einstein Telescope cryogenics and suspensions Open
The ETIC consortium will provide the R&D framework to investigate and validate possible configuration\nand solutions to be adopted for third generation gravitational-wave detector Einstein Telescope. The\ntwo facilities are dedicated to th…
View article: Outcome After Intestinal Transplantation From Living Versus Deceased Donors
Outcome After Intestinal Transplantation From Living Versus Deceased Donors Open
Objective: To describe the worldwide experience with living donation (LD) in intestinal transplantation (ITx) and compare short-term and long-term outcomes to a propensity-matched cohort of deceased donors. Background: ITx is a rare life-s…
View article: P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION Open
Even if allogeneic stem cell transplantation (allo-SCT) is curative for a minority of patients with multiple myeloma (MM), the patients who have relapsed after allo-SCT can experience long term survival, suggesting a synergy between anti-m…
View article: Supplementary Table S2 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S2 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Univariate logistic regression analysis for risk of having NSCLC.
View article: Supplementary Table S1 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S1 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Primers and probes of qMSP for Urine and Plasma samples
View article: Figure S4 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Figure S4 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Figure S4
View article: Supplementary Table S8 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S8 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Gene Methylation Detection, Sensitivity, Specificity Using Detectable vs. Non-detectable cutoff in whites
View article: Supplementary Table S11 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S11 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Univariate and multivariate logistic regression analysis for risk of having NSCLC in Black (n=38)
View article: Supplementary Table S3 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S3 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Correlation of Î"Ct methylation between Plasma and Urine
View article: Supplementary Table S6 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S6 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Univariate and multivariate logistic regression analysis for risk of having NSCLC in Early Stages (n=75)
View article: Supplementary Table S10 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Supplementary Table S10 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Univariate and multivariate logistic regression analysis for risk of having NSCLC in Whites (n=52)
View article: Figure S2 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Figure S2 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Figure S2
View article: Figure S3 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Figure S3 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Figure S3
View article: Figure S5 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Figure S5 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Figure S5
View article: Figure S6 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Figure S6 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer Open
Figure S6